Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Indikator
Negara-negara
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Pendapatan
Liburan
Negara-negara
Amerika Serikat
Inggris Raya
Kawasan Euro
Australia
Kanada
Jepang
Tiongkok
Brazil
Rusia
India
Selanjutnya Negara-negara
Indikator
Tingkat Bunga
Tingkat Inflasi
Tingkat Pengangguran
Pertumbuhan PDB (q-to-q)
Pdb Per Kapita
Transaksi Berjalan
Cadangan Emas
Utang Pemerintah
Produksi Minyak Mentah
Harga Bensin
Peringkat Kredit
Selanjutnya Indikator
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Apps
App Store
Google Play
Twitter
Light
Dark
System
Akebia Therapeutics | AKBA - Kewajiban Lancar
Keuangan
Harga Saham
USD 0.47
Aktiva
USD 342.13M
Kas Dan Setara
USD 159.25M
Biaya Penjualan
USD 10.34M
Aset Lancar
USD 220.79M
Kewajiban Lancar
USD 162.35M
UTANG
USD 46.51M
Dividen - Hasil
0
EBIT
USD -5.45M
EBITDA
USD 14.03M
Karyawan
167
Eps Laba Per Saham
USD -0.04
Modal Dan Cadangan
USD 20.37M
Laba Kotor Pada Penjualan
USD 47.28M
Beban Bunga Utang
342.13M
Modal Pinjaman
USD 12.78M
Kapitalisasi Pasar
USD 104.3M
Batas Pemasukan
USD -12.24M
Biaya Operasional
USD 63.08M
Laba Operasional
USD -5.45M
Modal Saham Biasa
USD 265.43M
Pe Harga Untuk Laba
1.63K
Laba Sebelum Pajak
USD -11.24M
Pendapatan Penjualan
USD 57.62M
Beban Penjualan Dan Administrasi
USD 23.53M
Saham
USD 18.7M
Kreditur Perdagangan
USD 7.61M
Debitur Perdagangan
USD 47.03M
Kewajiban Lancar
Perubahan
Tanggal
Acadia Pharmaceuticals
USD 332.22M
29.22M
2026-09
Agios Pharmaceuticals
USD 77.59M
7.37M
2026-09
Akebia Therapeutics
USD 162.35M
1.48M
2026-09
Alnylam Pharmaceuticals
USD 2.06B
550.49M
2026-09
Amgen
USD 23.23B
2.27B
2026-09
Ardelyx
USD 127.8M
4.42M
2026-09
Astellas Pharma
JPY 1.1T
134.96B
2026-09
AstraZeneca
USD 31.27B
286M
2026-09
Bayer
EUR 29.4B
2.87B
2026-09
BioMarin Pharmaceutical
USD 1.6B
59.17M
2026-09
Celltrion
KRW 288.01B
4.7B
2026-06
Cspc Pharmaceutical
CNY 10.18B
65.36M
2025-12
Deva Holding AS
TRY 6.43B
1.18B
2023-09
Dianthus Therapeutics
USD 28.51M
5.87M
2026-09
Exelixis
USD 411.88M
49.95M
2026-09
Fresenius Medical Care
EUR 7.91B
727.93M
2026-09
GlaxoSmithKline
GBP 20.72B
814M
2026-09
Ionis Pharmaceuticals
USD 435.29M
119.65M
2026-09
Ironwood Pharmaceuticals
USD 34.73M
1.88M
2026-09
J&J
USD 55.46B
562M
2026-09
Kangmei Pharma
CNY 5.1B
280.48M
2026-06
Karyopharm Therapeutics
USD 117.3M
25.24M
2026-03
Knight Therapeutics
CAD 165.26M
12.58M
2025-12
Laboratorios Farma
EUR 199.84M
121.75M
2023-12
Lexicon Pharmaceuticals
USD 9.9M
10.97M
2026-03
Malin Corporation
EUR 1000K
500K
2024-12
Medical Developments International
AUD 5.56M
2.26M
2025-12
Moderna
USD 2.03B
506M
2026-09
Nektar Therapeutics
USD 57.71M
4.17M
2026-03
Neuren Pharmaceuticals
AUD 4.34M
3.58M
2025-12
Organigram Holdings
CAD 107.28M
18.54M
2026-06
Ovoca Bio
EUR 1.3M
1.11M
2025-12
Pharma Mar
EUR 125.39M
26.97M
2026-09
Prothena
USD 11.43M
224K
2026-09
PTC Therapeutics
USD 776.08M
5.01M
2026-09
Qiagen NV
USD 581.45M
102.34M
2026-06
Regeneron Pharmaceuticals
USD 6.2B
671.5M
2026-09
Roche Holding
CHF 28.85B
846M
2026-06
Sanofi
EUR 29.77B
2.16B
2026-09
Sarepta Therapeutics
USD 656.35M
153.44M
2026-09
Sartorius
EUR 1.55B
102.8M
2026-09
Sino Biopharmaceutical
CNY 24.85B
5.29B
2025-06
Tectonic Therapeutic
USD 10.37M
2.59M
2026-06
Tilray
USD 259.32M
8.32M
2025-09
Vanda Pharmaceuticals
USD 145.16M
27.29M
2025-12
Zealand Pharma A/S
404M
260.96M
2026-03
Zz Pientze Pharmaceu
CNY 2.74B
277.02M
2026-09
×